AP MOLLER-MAERSK A/S-B (DP4B.DE) Fundamental Analysis & Valuation

Q: Can you provide the ChartMill fundamental rating for AP MOLLER-MAERSK A/S-B?

ChartMill assigns a fundamental rating of 3 / 10 to DP4B.DE.

FRA:DP4B • DK0010244508

2012 EUR

+4 (+0.2%)

Last: Apr 21, 2026, 07:00 PM

This DP4B.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1. DP4B.DE Profitability Analysis

1.1 Basic Checks

In the past year DP4B was profitable.
DP4B had a positive operating cash flow in the past year.
DP4B had positive earnings in each of the past 5 years.
In the past 5 years DP4B always reported a positive cash flow from operatings.

1.2 Ratios

With a Return On Assets value of 3.08%, DP4B is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
DP4B's Return On Equity of 4.90% is on the low side compared to the rest of the industry. DP4B is outperformed by 82.35% of its industry peers.
DP4B has a worse Return On Invested Capital (3.39%) than 70.59% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DP4B is below the industry average of 8.44%.

		Industry Rank	Sector Rank
ROA	3.08%
ROE	4.9%
ROIC	3.39%

ROA(3y)4.89%

ROA(5y)14.13%

ROE(3y)7.57%

ROE(5y)21.73%

ROIC(3y)4.88%

ROIC(5y)15.33%

1.3 Margins

DP4B's Profit Margin of 5.05% is on the low side compared to the rest of the industry. DP4B is outperformed by 76.47% of its industry peers.
DP4B's Profit Margin has declined in the last couple of years.
DP4B has a worse Operating Margin (5.30%) than 76.47% of its industry peers.
In the last couple of years the Operating Margin of DP4B has declined.
The Gross Margin of DP4B (21.21%) is worse than 88.24% of its industry peers.
In the last couple of years the Gross Margin of DP4B has declined.

		Industry Rank	Sector Rank
OM	5.3%
PM (TTM)	5.05%
GM	21.21%

OM growth 3Y-48.33%

OM growth 5Y-11.33%

PM growth 3Y-47.96%

PM growth 5Y-6.78%

GM growth 3Y-23.21%

GM growth 5Y-1.8%

More info and screens

ROA ROE ROIC Operating and Profit Margin Show most profitable peers

2. DP4B.DE Health Analysis

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DP4B is destroying value.
DP4B has less shares outstanding than it did 1 year ago.
DP4B has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, DP4B has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.47 indicates that DP4B is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.47, DP4B is in line with its industry, outperforming 58.82% of the companies in the same industry.
DP4B has a debt to FCF ratio of 3.81. This is a good value and a sign of high solvency as DP4B would need 3.81 years to pay back of all of its debts.
DP4B has a Debt to FCF ratio (3.81) which is comparable to the rest of the industry.
DP4B has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.27, DP4B is in the better half of the industry, outperforming 70.59% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.27
Debt/FCF	3.81
Altman-Z	2.47

ROIC/WACC0.46

WACC7.3%

2.3 Liquidity

A Current Ratio of 2.12 indicates that DP4B has no problem at all paying its short term obligations.
DP4B has a Current ratio of 2.12. This is in the better half of the industry: DP4B outperforms 70.59% of its industry peers.
DP4B has a Quick Ratio of 2.02. This indicates that DP4B is financially healthy and has no problem in meeting its short term obligations.
DP4B's Quick ratio of 2.02 is fine compared to the rest of the industry. DP4B outperforms 70.59% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.12
Quick Ratio	2.02

More info and screens

WACC Debt/Equity How to determine the health of a company Altman-Z score Show peers with great health

3. DP4B.DE Growth Analysis

3.1 Past

The earnings per share for DP4B have decreased strongly by -54.45% in the last year.
DP4B shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.98% yearly.
Looking at the last year, DP4B shows a decrease in Revenue. The Revenue has decreased by -2.69% in the last year.
The Revenue has been growing slightly by 6.32% on average over the past years.

EPS 1Y (TTM)-54.45%

EPS 3Y-51.97%

EPS 5Y3.98%

EPS Q2Q%-103.58%

Revenue 1Y (TTM)-2.69%

Revenue growth 3Y-12.84%

Revenue growth 5Y6.32%

Sales Q2Q%-8.65%

3.2 Future

Based on estimates for the next years, DP4B will show a decrease in Earnings Per Share. The EPS will decrease by -5.51% on average per year.
The Revenue is expected to grow by 2.54% on average over the next years.

EPS Next Y-104.37%

EPS Next 2Y-52.15%

EPS Next 3Y-33.36%

EPS Next 5Y-5.51%

Revenue Next Year-3.53%

Revenue Next 2Y-1.83%

Revenue Next 3Y0.14%

Revenue Next 5Y2.54%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks Show best growing peers

4. DP4B.DE Valuation Analysis

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.43 indicates a correct valuation of DP4B.
64.71% of the companies in the same industry are cheaper than DP4B, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.66. DP4B is valued rather cheaply when compared to this.
The Forward Price/Earnings Ratio is negative for DP4B. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	13.43
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DP4B indicates a rather cheap valuation: DP4B is cheaper than 82.35% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DP4B indicates a somewhat cheap valuation: DP4B is cheaper than 64.71% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	7.55
EV/EBITDA	4.72

4.3 Compensation for Growth

DP4B's earnings are expected to decrease with -33.36% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)3.37

EPS Next 2Y-52.15%

EPS Next 3Y-33.36%

More info and screens

Price/Earnings Price/FCF FCF per share EV/EBITDA PEG RATIO Show best valued peers

5. DP4B.DE Dividend Analysis

5.1 Amount

DP4B has a Yearly Dividend Yield of 3.05%.
DP4B's Dividend Yield is comparable with the industry average which is at 5.86.
Compared to an average S&P500 Dividend Yield of 1.81, DP4B pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	3.05%

5.2 History

On average, the dividend of DP4B grows each year by 50.43%, which is quite nice.

Dividend Growth(5Y)50.43%

Div Incr Years1

Div Non Decr Years1

5.3 Sustainability

93.47% of the earnings are spent on dividend by DP4B. This is not a sustainable payout ratio.
The Dividend Rate of DP4B has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.

DP93.47%

EPS Next 2Y-52.15%

EPS Next 3Y-33.36%

More info and screens

Find the best dividend stocks Show peers with best dividend

DP4B.DE Fundamentals: All Metrics, Ratios and Statistics

AP MOLLER-MAERSK A/S-B

FRA:DP4B (4/21/2026, 7:00:00 PM)

2012

+4 (+0.2%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupTransportation

GICS IndustryMarine Transportation

Earnings (Last)02-05 2026-02-05/bmo

Earnings (Next)05-07 2026-05-07/bmo

Inst Owners20.99%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap31.85B

Revenue(TTM)53.99B

Net Income(TTM)2.73B

Analysts40

Price Target1809.93 (-10.04%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	3.05%

Yearly Dividend142.15

Dividend Growth(5Y)50.43%

DP93.47%

Div Incr Years1

Div Non Decr Years1

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-63.1%

Min EPS beat(2)-129.84%

Max EPS beat(2)3.65%

EPS beat(4)2

Avg EPS beat(4)-23.23%

Min EPS beat(4)-129.84%

Max EPS beat(4)33.56%

EPS beat(8)5

Avg EPS beat(8)26.48%

EPS beat(12)9

Avg EPS beat(12)31.84%

EPS beat(16)11

Avg EPS beat(16)25.48%

Revenue beat(2)2

Avg Revenue beat(2)0.51%

Min Revenue beat(2)0.38%

Max Revenue beat(2)0.65%

Revenue beat(4)3

Avg Revenue beat(4)0.35%

Min Revenue beat(4)-1.86%

Max Revenue beat(4)2.23%

Revenue beat(8)5

Avg Revenue beat(8)0.16%

Revenue beat(12)5

Avg Revenue beat(12)-1.44%

Revenue beat(16)7

Avg Revenue beat(16)-1.28%

PT rev (1m)4.41%

PT rev (3m)11.1%

EPS NQ rev (1m)-924.02%

EPS NQ rev (3m)63.06%

EPS NY rev (1m)-1.65%

EPS NY rev (3m)-342.37%

Revenue NQ rev (1m)0.13%

Revenue NQ rev (3m)2.27%

Revenue NY rev (1m)2.47%

Revenue NY rev (3m)2.41%

Valuation

		Industry Rank	Sector Rank
PE	13.43
Fwd PE	N/A
P/S	0.69
P/FCF	7.55
P/OCF	3.84
P/B	0.67
P/tB	0.83
EV/EBITDA	4.72

EPS(TTM)149.81

EY7.45%

EPS(NY)-6.55

Fwd EYN/A

FCF(TTM)266.39

FCFY13.24%

OCF(TTM)524.02

OCFY26.04%

SpS2898.35

BVpS2983.87

TBVpS2424.47

PEG (NY)N/A

PEG (5Y)3.37

Graham Number3171.4 (57.62%)

Profitability

		Industry Rank	Sector Rank
ROA	3.08%
ROE	4.9%
ROCE	3.87%
ROIC	3.39%
ROICexc	3.94%
ROICexgc	4.72%
OM	5.3%
PM (TTM)	5.05%
GM	21.21%
FCFM	9.19%

ROA(3y)4.89%

ROA(5y)14.13%

ROE(3y)7.57%

ROE(5y)21.73%

ROIC(3y)4.88%

ROIC(5y)15.33%

ROICexc(3y)5.5%

ROICexc(5y)18.16%

ROICexgc(3y)6.52%

ROICexgc(5y)21.16%

ROCE(3y)5.56%

ROCE(5y)17.48%

ROICexgc growth 3Y-53.48%

ROICexgc growth 5Y-13.27%

ROICexc growth 3Y-53.64%

ROICexc growth 5Y-13.99%

OM growth 3Y-48.33%

OM growth 5Y-11.33%

PM growth 3Y-47.96%

PM growth 5Y-6.78%

GM growth 3Y-23.21%

GM growth 5Y-1.8%

F-Score4

Asset Turnover0.61

Health

		Industry Rank	Sector Rank
Debt/Equity	0.27
Debt/FCF	3.81
Debt/EBITDA	1.55
Cap/Depr	72.37%
Cap/Sales	8.89%
Interest Coverage	2.83
Cash Conversion	102.86%
Profit Quality	182.09%
Current Ratio	2.12
Quick Ratio	2.02
Altman-Z	2.47

F-Score4

WACC7.3%

ROIC/WACC0.46

Cap/Depr(3y)66.27%

Cap/Depr(5y)66.65%

Cap/Sales(3y)7.87%

Cap/Sales(5y)6.7%

Profit Quality(3y)151.91%

Profit Quality(5y)133.11%

High Growth Momentum

Growth

EPS 1Y (TTM)-54.45%

EPS 3Y-51.97%

EPS 5Y3.98%

EPS Q2Q%-103.58%

EPS Next Y-104.37%

EPS Next 2Y-52.15%

EPS Next 3Y-33.36%

EPS Next 5Y-5.51%

Revenue 1Y (TTM)-2.69%

Revenue growth 3Y-12.84%

Revenue growth 5Y6.32%

Sales Q2Q%-8.65%

Revenue Next Year-3.53%

Revenue Next 2Y-1.83%

Revenue Next 3Y0.14%

Revenue Next 5Y2.54%

EBIT growth 1Y-51.61%

EBIT growth 3Y-54.96%

EBIT growth 5Y-5.73%

EBIT Next Year105.12%

EBIT Next 3Y28.92%

EBIT Next 5Y29.47%

FCF growth 1Y-31.15%

FCF growth 3Y-45.3%

FCF growth 5Y-5.27%

OCF growth 1Y-14.44%

OCF growth 3Y-34.34%

OCF growth 5Y4.51%

AP MOLLER-MAERSK A/S-B / DP4B.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AP MOLLER-MAERSK A/S-B?

ChartMill assigns a fundamental rating of 3 / 10 to DP4B.DE.

Can you provide the valuation status for AP MOLLER-MAERSK A/S-B?

ChartMill assigns a valuation rating of 3 / 10 to AP MOLLER-MAERSK A/S-B (DP4B.DE). This can be considered as Overvalued.

What is the profitability of DP4B stock?

AP MOLLER-MAERSK A/S-B (DP4B.DE) has a profitability rating of 2 / 10.

What are the PE and PB ratios of AP MOLLER-MAERSK A/S-B (DP4B.DE) stock?

The Price/Earnings (PE) ratio for AP MOLLER-MAERSK A/S-B (DP4B.DE) is 13.43 and the Price/Book (PB) ratio is 0.67.

How financially healthy is AP MOLLER-MAERSK A/S-B?

The financial health rating of AP MOLLER-MAERSK A/S-B (DP4B.DE) is 6 / 10.